Ai Irisawa

Incidence of and risk factors for severe neutropenia during treatment with the modified FOLFIRINOX therapy in patients with advanced pancreatic cancer

Hideaki Takahashi, Kazuo Watanabe, M. Ikeda, 2022, Scientific Reports.

Characterization of low active ghrelin ratio in patients with advanced pancreatic cancer

A. Ochiai, Hideaki Takahashi, M. Ikeda, 2018, Supportive Care in Cancer.

The “histological replacement growth pattern” represents aggressive invasive behavior in liver metastasis from pancreatic cancer

M. Kojima, A. Ochiai, T. Akimoto, 2020, Cancer medicine.